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ABSTRACT
Background and the purpose of the study: Heat Shock Protein 90 (Hsp90) is typically the most 
abundant chaperone in the eukaryotic cell cytoplasm, and its expression is essential for loading 
immunogenic peptides onto major histocompatibility complex molecules for presentation to T-
cells. Therefore, it may act as a good candidate as an adjuvant molecule in vaccine technology. 
Methods: Initially the human Hsp90β gene was cloned into the heat inducible expression vector 
pGP1-2 and then the recombinant protein was isolated by ion exchange chromatography. After 
intradermal injection of confirmed purified band of protein to rabbits and isolation of the serum 
IgG antibody, for its affinity purification, the rabbit’s purified Hsp90 specific IgG was coupled 
to the cyanogen bromide-activated Sepharose 4B.  
Results: The recovery of the purified protein of interest by affinity chromatography was 50% .
Conclusion: This research enabled purification of human heat shock protein by a laboratory 
prepared column chromatography. 
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INTRODUCTION
Hsp90 (heat shock protein 90) is a molecular chaperone 
that modulates the stability and/or transport of a diverse 
set of critical cellular regulatory including metabolism, 
organization, and signaling proteins. Binding to Hsp90 
is required for normal function of many proteins (1). 
In addition purified heat shock proteins (Hsps) can be 
applied in several aspects of biology, medicine and 
protein biotechnology. In mammalian cells, there are 
two genes encoding cytosolic Hsp90 homologues with 
the human Hsp90α which show 85% sequence identity 
to  Hsp90β  (2,3).  The  protein  has  been  implicated 
in  loading  immunogenic  peptides  onto  major 
histocompatibility complex molecules for presentation 
to T cells(4,5). They are immunogenic and can be used 
for anticancer vaccines(6).     
Immunoaffinity  purification  is  a  highly  specific 
and  reversible  technique(7)  which  was  used  in  this 
investigation  to  produce  the  recombinant  Hsp90 
without using any chemicals as a convenient adjuvant 
and chaperone in human vaccines. 
MATERIAL  AND  METHODS
Cell line and Plasmids
The MDA-MB468 cell line was obtained from the 
Pasteur  Institute  of  Iran.  Escherichia  coli  strains 
NovaBlue and DH5α were purchased from Invitrogen, 
USA. pTZ57R (Fermentas, Germany) and pGP1-2 
(donated by Dr. Bagher Yhakhchali NIGEB, Tehran, 
Iran) were plasmids which were used in this study. 
Human Hsp90 polyclonal antibody was purchased 
from Abcam, UK. 
Cell culture and stimulation
The MDA- MB468  cell line was maintained in RPMI 
(Roswell Park Memorial Institute, Sigma, Germany) 
containing  2mM  L-glutamine  (Sigma,  Germany), 
100 U/ml penicillin (Sigma, Germany), and 100μg/ml 
streptomycin (Sigma, Germany) supplemented with 
10% fetal bovine serum(Gibco,UK)(8). The plateau 
level for these cultures was about one million viable 
cells/ml. The sufficient flasks were induced by 50 
ng  of  phorbol  myristate  acetate  (PMA)(  Sigma, 
Germany) without any physical manipulation(9). 
RT –PCR and Cloning into the pGP1-2 vector
The MDA-MB468 cell line was analyzed for Hsp90 
expression. The total RNA was extracted by RNeasy 
mini kit (Qiagen, USA ,74104) and the generation 
of  cDNA  and  PCR  was  carried  out  by  C.therm 
Polymerase  One-Step  RT-PCR  System  (Roche, 
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Germany,  12016338001).  Specific  primers  were 
designed  by  Generunner  software:  H90F,  5’TC 
CGG ACC TGA GGA AGT GCA CCA3’ and H90R, 
5’ GGT NAC CCT AAT CGA CTT CTT CCA TGC 
3’ (10). The Hsp90 gene PCR product was cloned 
into the pTZ57R T-vector (Fermentas, Lituvania) as 
described previously(11). The recombinant plasmid 
was  constructed  by  using  the  Kpn2I  and  BstEII 
restriction enzymes (Fermentas, Lituvania).  
Expression, primary purification and analysis of 
the human Hsp90β subunit
The Nova Blue strain of E. coli was transformed 
using above construct and protein expression was 
performed in LB (Lorian Bertani) medium containing 
15μg/ml  of  kanamycine  (Fermentas,  Lituvania) 
(12,13). The  heat  induced  culture  of  expressed 
Novablue strain of Ecoli with pGpHsp (pGP1-2 & 
human Hsp90β subunit) was prepared and analyzed 
as described previously (14). 
Polyclonal antibody production in Rabbits
The  purified  Hsp90β  (10  μg)  prepared  from 
acrylamide as described previously (15) was used for 
immunization of rabbits subcutaneously. The serum 
antibody response was determined after secondary 
immunization  by  double  diffusion  test  and  also 
following booster injection (16). 
Preparation of the Hsp90β -specific IgG Sepharose 
4B column
In this stage the common carotid artery of injected 
rabbits  was  used  to  collect  large  amount  of  blood 
after  anesthetizing  by  100-150  mg/kg  ketamine 
(Merck, Germany). The IgG antibody of rabbits sera 
was isolated by column chromatography using 3ml 
protein A resin (17). Rabbit’s purified IgG was used as 
ligand to designe the affinity chromatography column, 
as  follow.  For  affinity  purification  of  antibodies, 
immunoadsorbent columns were prepared with Hsp90β 
coupled to cyanogen bromide-activated Sepharose 4B 
(GE  Healthcare  Bio-sciences,Sweden,17-0430-01) 
(www6.gelifesciences.com).The  above  procedure 
allowed coupling of all specific IgG antibody (IgG pI 
3-9) against HSP90 protein  which were coupled to 
cyanogen bromide-activated Sepharose 4B.
Final  Hsp90β  purification  by  Hsp-specific  IgG 
Sepharose 4B column
The  heat  induced  culture  was  harvested  and  the 
extracted protein was used for purification of the 
Hsp90 by the prepared affinity column as described 
above.  The    proceed  lysate  (10ml)  was  loaded 
onto  the  immunoadsorbent  column  at  a  flow  rate 
of 0.5 ml/min. Bound proteins were eluted using a 
glycine-HCl (0.1M) and 2M NaCl at pH 5 ( www6.
gelifesciences.com ) and confirmed by the double 
diffusion test and western blotting using a human 
Hsp90 polyclonal antibody.  
RESULTS
The  present  study  demonstrates  solation  of  the 
recombinant human Hsp90β subunit by ion exchange 
chromatography after cloning and expression of the 
RT-PCR product (Fig1). Figure 1 shows the 2174 bp 
PCR product representing the human Hsp90 gene. 
Figure 1: PCR product of 
Hsp90β on 1% agarose gel
Lane 1: 100 bp DNA Ladder 
(Fermentas, Germany)  
Lane 2: 2174 bp Hsp90 
PCR product
Figure 2: pGp1-2 subcloning confirmation 
Lane 1: Undigested cloned plasmid 
Lane 2: Gene Ruler 1kb  DNA Ladder   
(Fermentas, Germany)                             
Lane  3:  Digested  plasmid  by  DraII 
(linear form)
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Figure 2 shows confirmation of subcloning of Hsp90β 
segment by DraII restriction enzyme digestion. Also, 
this vector contained the kanamycine resistance gene 
and  after  transformation,  bacteria  could  grow  on 
medium  supplemented  with  30μg/ml  kanamycine. 
The  resulting  clone  was  amplified  using  Hsp90 
specific primers (Fig 3).
The  160  fractions  obtained  from  ion  exchange 
chromatography of the expressed bacterial cells were 
determined  by  a  biophotometer  in  280  nm  (Fig 
4&5). According to our findings the chromatography 
parameters were regularized as: resolution 2, selectivity 
2.5, efficiency 4 and capacity 30%.
The  Hsp90  protein  required  for  preparation  of  a 
Figure 3:  Confirmation  of 
Hsp90 Cloning into the pGP1-2 
by specific PCR
Lane  a:  Gene  Ruler  1kb 
DNA  Ladder  (Fermentas, 
Germany)  
Lane b: Direct PCR product 
of cloned plasmid
Figure  4:  Showing  Hsp90β  subunit  purification 
chromatogram of fractions obtained from ion exchange 
chromatography of expressed construct
a, b: Loading & washing stages 
c: Elution stage 
d, e , f: Washing stage
specific  affinity  chromatographic  procedure  was 
obtained by gel extraction of 90kDa band of fraction 
C (in figure 4) and confirmed by western blotting 
using polyclonal antibody against Hsp90β subunit 
(Fig  9). 
Figures 6 & 7 show the result of IgG isolation by 
different  stages  of  the  protein  A  column 
chromatography and its electrophoresis with non-
reducing  gel.  While  in  the  native  IgG  sample 
(lane c), a single predominant band is observed, the 
reduced IgG sample by DTT in lane b shows two 
bands related to light and heavy chains of antibody.
In  order  to  obtain  pure  Hsp90  by  simple  affinity 
chromatography with recovery 50%, the interested 
Figure 5: 10% SDS-PAGE of obtained fractions 
which are the peaks signed in fig.4 .It was showed 
90kDa protein band in lane c.
Figure 6: Chromatogram of IgG purification from serum 
by protein A affinity chromatography 
1- 3 –11: Loading 
2- 12- 22: Washing
3- 23 – 25: Elution      
4- 26–30: Washing 
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protein  was  identified  by  double  diffusion  and 
western blotting tests (Fig. 8, 9).
 
DISCUSSION
Hsps have a variety of important and functions in 
immunity (5) and stimulate a wide range of innate 
and adaptive immune responses. The peptide binding 
function  allows  chaperon  proteins  such  as  Hsp90, 
Hsp70, and gp96 to acquire antigenic proteins within 
the cells when administered outside of the cell to 
induce priming of CD8+ T lymphocytes in vivo(18). 
The main aim of the present study was to establish 
Figure  7: 10% SDS-PAGE of Ig G after 
Protein A affinity chromatography                                                                       
Lane a: Total serum proteins
Lane b: Boiling with SDS sample buffer
Lane c: Purified IgG
Figure 8: Immuno diffusion test using injected rabbit serum (+) 
and negative control (-)
1- Rabbit’s serum without injection
2- Purified Hsp90 band by gel extraction
3- Immunized rabbit’s serum
Figure  9:  Western  Blotting  of 
recombinant  protein  purified  by 
βHsp90-  specific    sepharose  4B 
using polyclonal antibody
an efficient and easy-to-use method for purification 
of  Hsp90β.  In  immunoaffinity  chromatography 
which  can  be  considered  as  a  subset  of  affinity 
chromatography, an immunoglobulin is used to bind 
analyte molecules. Because immunoglobulins show 
exquisite specificities towards antigens which  are 
IgG without s-s band
IgG
105
90KDa
used in their production, immunoaffinity columns 
are ideal for purification of the targeted analytes 
(3).  This  study  proposes  that  the  specific  IgG 
antibody  against  Hsp90  protein  could  be  used 
for its purification by affinity chromatography; is 
highly selective for Hsp90 and has an appropriate 
affinity  for  this  molecule. This  strategy  in  which 
antibodies are immobilized in a single orientation 
generally involves immobilization of an intermediate 
protein such as protein A that specifically binds to 
the Fc region of an antibody and it can be coupled 
to a suitable commercially available matrix without 
affinity loss. In this study, the pGp1-2 expression 
vector was initially used for production of Hsp90. A 
heat-induced transition of Hsp90 was then necessary 
to exert the chaperone activity (18). This treatment 
which  caused  self-oligomerization  of  Hsp90 
under  substrate-free  conditions  indicates  a  close 
relationship  between  self-oligomerization  and  the 
substrate-binding properties. Many in vitro  studies 
on  the  chaperone  function  of  Hsp90  have  been 
performed  around  25°C  and  are  triggered  by  the 
addition of denatured proteins in renatured buffers 
containing Hsp90 without other chaperones and 
co-chaperones (19). 
CONCLUSIONS
In this study natural and oligomeric forms of the 
Hsp90β  subunit  were  produced  by  the  designed 
affinity  chromatographic  purification  procedure 
without using any tag peptides or other materials 
such as IPTG leading to 50% recovery. In future 
chaperoning  and  adjuvant  effects  of  Hsp90  in 
recombinant vaccines will be investigated. 
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